IL-1-driven stromal–neutrophil interactions define a subset of patients with inflammatory bowel disease that does not respond to therapies

Friedrich, M., Pohin, M., Jackson, M. A., Korsunsky, I., Bullers, S. J., Rue-Albrecht, K., Christoforidou, Z., Sathananthan, D., Thomas, T., Ravindran, R., Tandon, R., Peres, R. S., Sharpe, H., Wei, K., Watts, G. F. M., Mann, E. H., Geremia, A., Attar, M., Barone, F., Brenner, M., Buckley, C. D., Coles, M., Frei, A. P., Lassen, K. G., Powrie, F. M., McCuaig, S., Thomas, L., Collantes, E., Uhlig, H. H., Sansom, S. N., Easton, A., Raychaudhuri, S., Travis, S. P. and Powrie, F. M. IL-1-driven stromal–neutrophil interactions define a subset of patients with inflammatory bowel disease that does not respond to therapies. Nature Medicine. 2021. doi: 10.1038/s41591-021-01520-5

Privacy Preference Center

Necessary

Advertising

Analytics

Other